KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables Refunds
Ratios

BioNTech SE (BNTX) Other Gross PP&E Adjustments (2018 - 2025)

BioNTech SE's Other Gross PP&E Adjustments history spans 8 years, with the latest figure at -$244.7 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 7.71% to -$244.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$244.7 million, a 7.71% increase, with the full-year FY2025 number at -$237.5 million, up 10.42% from a year prior.
  • Other Gross PP&E Adjustments hit -$244.7 million in Q4 2025 for BioNTech SE, down from -$235.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for BNTX hit a ceiling of -$142.8 million in Q1 2021 and a floor of -$276.1 million in Q2 2024.
  • Historically, Other Gross PP&E Adjustments has averaged -$237.5 million across 5 years, with a median of -$239.8 million in 2025.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 91.8% in 2021 and later increased 21.8% in 2023.
  • Tracing BNTX's Other Gross PP&E Adjustments over 5 years: stood at -$226.4 million in 2021, then rose by 4.51% to -$216.2 million in 2022, then fell by 6.7% to -$230.7 million in 2023, then fell by 14.93% to -$265.1 million in 2024, then grew by 7.71% to -$244.7 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for BNTX at -$244.7 million in Q4 2025, -$235.0 million in Q3 2025, and -$253.9 million in Q2 2025.